Showing 501 - 520 results of 635 for search '(( significantly larger decrease ) OR ( significantly weaker decrease ))', query time: 0.39s Refine Results
  1. 501

    Table 1_A real-world study of polyenyl phosphatidylcholine in the management of patients with metabolic dysfunction-associated fatty liver disease in China clinical practice.docx by Yi Pan (68170)

    Published 2025
    “…In the PPC group, baseline alanine transaminase (ALT) levels decreased at 12- and 24-weeks compared to those of the control group, but results were not significant. …”
  2. 502

    Data Sheet 1_Factors associated with cognitive flexibility in people with opioid-use disorder: a pilot study.docx by Paul S. Regier (8277792)

    Published 2024
    “…Impulsiveness, social function, and depressive symptoms were highly inter-related; however, only higher impulsiveness (r = -.48, p = 0.006) and more social impairment (r = -.47, p = 0.007) significantly correlated with decreased CET (but not n-Back) performance. …”
  3. 503

    Table 1_Inhibitory control in the sober state as a function of alcohol sensitivity: a pilot functional magnetic resonance imaging (fMRI) study.docx by Roberto U. Cofresí (20800094)

    Published 2025
    “…Based on these preliminary findings, future studies with larger samples are warranted to determine the extent to which domain-general IC performance associated with fronto-cortico-striatal IC circuit activation contributes to the alcohol use pathophysiology, and whether therapeutic interventions (e.g., non-invasive brain stimulation) targeting fronto-cortico-striatal IC circuitry may decrease AUD symptomatology.…”
  4. 504

    Table 2_Inhibitory control in the sober state as a function of alcohol sensitivity: a pilot functional magnetic resonance imaging (fMRI) study.docx by Roberto U. Cofresí (20800094)

    Published 2025
    “…Based on these preliminary findings, future studies with larger samples are warranted to determine the extent to which domain-general IC performance associated with fronto-cortico-striatal IC circuit activation contributes to the alcohol use pathophysiology, and whether therapeutic interventions (e.g., non-invasive brain stimulation) targeting fronto-cortico-striatal IC circuitry may decrease AUD symptomatology.…”
  5. 505

    Effect of inhibitors on model parameters as inferred by SBI. by Johannes C. J. Heyn (21567894)

    Published 2025
    “…(a) Latrunculin A significantly decreases the actin network extension rate V<sub>e</sub><sup>0</sup> for both MDA-MB-231 and MCF-10A cells while leaving all other parameters unchanged. …”
  6. 506

    Data Sheet 2_Assessing the impact of moxibustion on colonic mucosal integrity and gut microbiota in a rat model of cerebral ischemic stroke: insights from the “brain-gut axis” theo... by Yi-Xia Ding (20792930)

    Published 2025
    “…</p>Result<p>The model group exhibited significantly higher Longa scores, larger brain infarct size, and higher serum FITC-Dextran levels and ET-1 levels when compared with the sham surgery group (p < 0.01). …”
  7. 507

    Data Sheet 1_Assessing the impact of moxibustion on colonic mucosal integrity and gut microbiota in a rat model of cerebral ischemic stroke: insights from the “brain-gut axis” theo... by Yi-Xia Ding (20792930)

    Published 2025
    “…</p>Result<p>The model group exhibited significantly higher Longa scores, larger brain infarct size, and higher serum FITC-Dextran levels and ET-1 levels when compared with the sham surgery group (p < 0.01). …”
  8. 508

    Data from: Decade-long bird trends in China: Stable species richness but increasing biotic homogenization by Jiekun He (20964269)

    Published 2025
    “…In contrast, functional richness increased significantly (Zr = 0.122, 95% CI = [0.016; 0.227]). …”
  9. 509

    Supplementary file 1_Wearable-derived heart rate variability and sleep monitoring as predictors of mood episodes in bipolar disorder: a case report.jpg by Aiko Eto (22769225)

    Published 2025
    “…The findings revealed that reductions in nocturnal RMSSD preceded the onset of depressive symptoms, while decreases in time spent in bed were significantly associated with the exacerbation of manic symptoms. …”
  10. 510

    Table 1_Declining trends in sweetness of the diet in the United Kingdom: 2008/9–2018/19.docx by Inga Kutepova (20873687)

    Published 2025
    “…Overall, the decline in ASE was larger for beverages than foods (ASE values declined 20.7% for beverages vs. 4.4% for foods), although both decreased significantly (p-value < 0.01). …”
  11. 511

    Table 1_Effect of high-intensity intermittent rehabilitation training on physical function, gut microbiome and metabolite after percutaneous coronary intervention in patients with... by Lei Jiang (73366)

    Published 2024
    “…</p>Results<p>The 6MWT showed significantly greater improvement in the HIIT group compared to the MCT group (P = 0.0024). …”
  12. 512

    Effect of appetite suppressants on head-weaving stereotypy in female rats. by Axl Lopez (21594203)

    Published 2025
    “…However, unlike males (CV = 37.8%), there was significant variability between subjects (CV = 49%) and across days. …”
  13. 513

    Data_Sheet_1_Subthreshold amyloid deposition, cerebral small vessel disease, and functional brain network disruption in delayed cognitive decline after stroke.docx by Jae-Sung Lim (532986)

    Published 2024
    “…Given the limited number of patients and potential residual confounding, our results should be considered hypothesis-generating and need replication in larger cohorts in the future.</p>…”
  14. 514

    Supplementary Material for: Seraph-100 hemoperfusion for management of severe COVID-19: Assessment of serum and plasma analytes pre- and post-filtration by Rouse M. (20413172)

    Published 2024
    “…However, multiple circulating proteins with roles in inflammation, endothelial/epithelial damage and/or angiogenesis decreased significantly across the filter. Larger prospective trials will be required to determine if such transient reductions translate into improved patient outcomes. …”
  15. 515

    Image 1_Differential Ca2+ handling by isolated synaptic and non-synaptic mitochondria: roles of Ca2+ buffering and efflux.tif by Jyotsna Mishra (3703195)

    Published 2025
    “…Since, non-synaptic mitochondria displayed a significantly reduced ss[Ca<sup>2+</sup>]<sub>e</sub>, this suggested a larger mCa<sup>2+</sup> buffering capacity to maintain [Ca<sup>2+</sup>]<sub>m</sub> with increasing mCa<sup>2+</sup> loads. …”
  16. 516

    Image 2_Differential Ca2+ handling by isolated synaptic and non-synaptic mitochondria: roles of Ca2+ buffering and efflux.tif by Jyotsna Mishra (3703195)

    Published 2025
    “…Since, non-synaptic mitochondria displayed a significantly reduced ss[Ca<sup>2+</sup>]<sub>e</sub>, this suggested a larger mCa<sup>2+</sup> buffering capacity to maintain [Ca<sup>2+</sup>]<sub>m</sub> with increasing mCa<sup>2+</sup> loads. …”
  17. 517

    Image 3_Differential Ca2+ handling by isolated synaptic and non-synaptic mitochondria: roles of Ca2+ buffering and efflux.tif by Jyotsna Mishra (3703195)

    Published 2025
    “…Since, non-synaptic mitochondria displayed a significantly reduced ss[Ca<sup>2+</sup>]<sub>e</sub>, this suggested a larger mCa<sup>2+</sup> buffering capacity to maintain [Ca<sup>2+</sup>]<sub>m</sub> with increasing mCa<sup>2+</sup> loads. …”
  18. 518

    Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  19. 519

    Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”
  20. 520

    Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi... by Gyeong Ho Baek (21382907)

    Published 2025
    “…</p>Results<p>NuGel (0.3% [Nu0.3] and 0.5% [Nu0.5]) was well-tolerated, with no adverse drug reactions or serious adverse events. Nu0.3 showed a significant decrease in EASI score from baseline (-12.2%, [-30.3%, 5.9%], p = 0.04). …”